Loading...
NYSE: OSCR
Oscar Health, Inc.
Healthcare · Medical - Healthcare Plans
Market Cap
$3.17B
52w High
$23.80
52w Low
$11.20
P/E
-7.80
Volume
9.44M
Outstanding Shares
259.27M
Price vs Fundamentals
Why The Stock Is Moving
Likely multiple compressionModerate confidence
1Y Price: -12.54%Revenue (TTM): 27.49%FCF (TTM): 11.38%P/FCF: 0th pct
What changed
The stock fell 12.54% over the last year. Revenue grew 27.49% over the trailing twelve months. Operating margin moved from 0.43% to -3.39%. Free cash flow grew 11.38% over the trailing twelve months.
What the market seems to be pricing
Visible fundamentals weakened far less than the stock price, and the shares now sit around the 0th percentile of their historical P/FCF range. That looks more like a rerating of the multiple than a collapse in the business.
What would invalidate this read
This read changes if operating margin (currently -3.39%) continues to decline, or if revenue growth turns negative. The bull case requires the business to hold its current trajectory.
Company profile
Oscar Health, Inc. provides health insurance products and services in the United States.
CEOMark Thomas Bertolini
SectorHealthcare
IndustryMedical - Healthcare Plans
Employees2,400
IPO dateMar 3, 2021
Valuation
Forward P/E—
EV/EBITDA-3.65
Enterprise value$1.43B
Price / Book3.24
Stock splits
No stock splits recorded for this ticker.
Profitability & growth
Standard profitability metrics can be misleading for financial/insurance companies. GAAP requires unrealized investment gains/losses in net income (affecting ROE), and margins are blended across diverse business segments.
Revenue growth17.25%
Gross margin14.38%▼28.48%vs FY2024
Operating margin-3.39%▼642.86%vs FY2024
ROE-45.33%▼1906.55%vs FY2024
Analyst consensus
RatingHold
Target price$16.40▲34.32%
2
Buy
6
Hold
2
Sell
⚠ Analyst ratings tend to be lagging indicators — upgrades often follow price gains rather than precede them. Use as one signal among many.
Earnings
Last 3 reported quarters plus the next estimate. Switch into compare mode to inspect one metric year-over-year.
Next report
May 12, 2026
View
EPS
Actual vs estimate by quarter
Q3FY25
ActualEst.
-$0.89
-$0.90
Q4FY25
ActualEst.
-$0.53
-$0.55
Q1FY26
ActualEst.
-$1.24
-$0.92
Q2FY26
Next Est.
—
Revenue
Actual vs estimate by quarter
Q3FY25
ActualEst.
$2.86B
$3.07B
Q4FY25
ActualEst.
$2.99B
$3.05B
Q1FY26
ActualEst.
$2.81B
$3.12B
Q2FY26
Next Est.
—